Implantation Rate of Vitrified-warmed Collapsed Blastocysts
Launched by CENTRE FOR REPRODUCTIVE MEDICINE, BELGIUM · Nov 4, 2013
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • female age \<39 years
- • at least 1 blastocyst available for cryopreservation
- Exclusion Criteria:
- • sperm origin: testicular or epididymal sperm extraction
- • IVM (in-vitro maturation) cycles
- • PGD cycles (preimplantation genetic diagnosis)
About Centre For Reproductive Medicine, Belgium
The Centre for Reproductive Medicine in Belgium is a leading institution dedicated to advancing reproductive health through innovative clinical research and comprehensive patient care. With a focus on infertility treatment and reproductive technologies, the Centre conducts cutting-edge clinical trials aimed at improving outcomes for individuals and couples facing reproductive challenges. Supported by a team of experienced specialists and researchers, the Centre prioritizes patient safety and ethical standards while contributing to the global body of knowledge in reproductive medicine. Its commitment to excellence and research-driven practices positions it as a pivotal player in the field of reproductive health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Patients applied
Trial Officials
Lisbet Van Landuyt, MSc
Principal Investigator
Centre for Reproductive Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials